Biomerica to Participate in Upcoming Investor Conferences
June 04 2021 - 8:00AM
Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced
medical products, today announced that it will be participating in
two upcoming investor conferences: the Truist Life Sciences Series
and LD Micro Invitational XI event.
Zack Irani, Chief Executive Officer of Biomerica
will be presenting virtually at the LD Micro Invitational XI event
on Tuesday, June 8th at 2:30 PM ET. Register to access the LD Micro
Invitational XI here.
Biomerica will also be conducting one-on-one
investor meetings as part of the Truist Life Science Series on
Thursday, June 10th.
About Biomerica (NASDAQ:
BMRA)
Biomerica, Inc. (www.biomerica.com) is a global
biomedical technology company that develops, patents, manufactures
and markets advanced diagnostic and therapeutic products used at
the point of care (in home and in physicians' offices) and in
hospital/clinical laboratories for detection and/or treatment of
medical conditions and diseases. The Company's products are
designed to enhance the health and well-being of people, while
reducing total healthcare costs. Biomerica’s primarily focus is on
gastrointestinal and inflammatory diseases where the Company has
multiple diagnostic and therapeutic products in development.
Corporate Contact:
John Nesbett /Jennifer Belodeau IMS Investor
Relations 203.972.9200 jnesbett@institutionalms.com
Biomerica (NASDAQ:BMRA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Biomerica (NASDAQ:BMRA)
Historical Stock Chart
From Apr 2023 to Apr 2024